Patent · US Active

Crystal form of epothilone B and use in pharmaceutical compositions

US8178566B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Ernst Kusters · Sankt Goarshausen, DE
Michael Mutz · Glückstadt, DE
Frank Stowasser

Key dates

Filing date	Aug 14, 2007
Grant date	May 15, 2012
Priority date	—
Expiry date	Jan 5, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to new crystal forms of epothilone B.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.